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Abstract
The model of the human glucose-insulin system plays an important role in several clinical treatment methods and
protocols, like tight glycemic control of intensive care patients. The Intensive Control Insulin-Nutrition-Glucose
(ICING) model is one of these protocols that was used for the development of the Stochastic Targeted glucose
control (STAR) protocol applied as a standard of care in New Zealand and Hungary. The original ICING model
uses an ordinary differential equations (ODE) for the description of the glucose-insulin metabolic system.Recent
studies attempted the extension of the original ICING model with stochastic terms resulting a new stochastic
differential equations model(SDE). By using the resulted of this new model (SDE) we may have the chance to
improve the accuracy of ICING modeling (reduce the modelling error) which can results a better clinical treatment
using STAR. In the study presented in this paper, the potential use and implementation of the stochastic version
of the ICING model (SDE), was analysed and the moddeling error was compared with the original version of the
model using a large clinical data set including treatment records of 60 patients from Belgium, Hungary and New
Zealand. The results show that the SDE model gives a smaller modeling error compared to the ICING model in
most of patients.These results suggest that SDE model may be used to improve the prediction process of the blood
glucose level of the ICU patients which will be an important step of the STAR protocol.
1. Introduction
Intensive care patients often experience hyperglycemia (high
blood glucose levels) and high levels of insulin resis-
tance caused by stress, which have been linked to in-
creased morbidity and mortality in intensive care units (ICU)
1.Controlling blood glucose proved to be difficult due the
risk of hypoglycemia (low blood glucose levels) and the
highly variable state of the patient. It has been shown that
tight glycemic control (TGC) was able to reduce the negative
outcomes related to poor control with 17-45% reductions in
mortality by controlling BG to normal levels 3,also Manag-
ing and quantifying hyper/hypoglycemia risk as a function
of inter/intra-patient metabolic state variability which con-
sidered to be an important step in TGC by minimizing the
risk of unintended harmful.
Stochastic Targeted (STAR) protocol is a model based
TGC framework which can be applied in a wide range of
clinical scenarios and approaches, it uses deterministic and
stochastic models to regulate and control BG levels, work-
load and patient safety within a predefined risk management
approach.STAR is a patient specific controller that man-
age inter/intra-patient variability using a stochastic forecast-
ing of patients potential metabolic variability in conjunc-
tion with ICING model (Intensive Care Insulin-Nutrition-
), a mathematical model used to simulate the fundamental
metabolic dynamics of the human body 3456.
ICING is a deterministic models that uses an ordinary
differential equation to describe the physiological system
to help the STAR controller select the optimal glucose /in-
sulin inputs in order to manage BG levels. These kind
of models known as imperfect in the sense that modeling
the uncertainty, system noise and the stochastic nature of
the physiological system are not taken into consideration
7.ICING Models parameters was estimated and the identi-
fication of the insulin sensitivity SI (SI is representative of
whole body metabolic state condition as a single parame-
ter) was achieved via an integral based method. In this way
all the dynamic error were lumped into the SI profile which
caused unacceptable high variability in the blood glucose
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levels. To solve this problem and try to regularize the SI
profile, an additional stochastic term was suggested in the
glucose equation, which can captures the unmodulated dy-
namics and measurement noise 8.
Palancz et al in 8 investigated the stochastic Ito version of
the ICING model (SDE) equations with parametric stochas-
tic noise term. The computation of the system trajectories
and their statistical futures were carried out using Runge-
Kutta method in the presences of Wiener-type diffusion pro-
cess term. Parameter estimation is achieved via maximum
likelihood technique. The stochastic model allows not only
the characterization of the noise integrated in the stochastic
term but also enables the reduction of the modeling error.
The aim of this work is to Analyses the potential use and
implementation of the new stochastic differential equation
ICING (SDE) model in STAR protocol by analyzing the
modeling error and comparing it to the original ordinary dif-
ferential equation version using a large clinical data set of




The Intensive Care Insulin-Nutrition-Glucose (ICING)
model used in this study to simulate the fundamental
metabolic dynamics of the human body which relies on a de-
terministic ordinary deferential equation model (ODE) that
describes the physiological system to help select glucose
and insulin inputs in order to facilitate control9. The ICING
































P(t) = min(d2P2(t),Pmax)+PN(t), (6)
uen(t) = min(max(umin,k1G(t)+ k2) ,umax) . (7)
The model parameters, the inputs variables, and their de-
tailed description can be found in 10.
2.2. Stochastic ICING
In the stochastic version of the ICING model (SDE) an addi-
tional stochastic term was suggested in the glucose equation
incorporating a stochastic behavior of the human metabolic
system, like modelling error, unmodulated dynamics and
system noise etc. 8. SDE can be considered as an extension
of the ICING model by introducing a system noise in form














Where σ(t) is a so called diffusion term depending on
time and W(t) is a Wiener process, also known Brownian
motion, a continuous time random walk, practically it is in-
tegrated white noise process:
dW
dt
(t) =N (t). (9)
3. Clinical data
The clinical data used in this study was collected from three
independent cohorts of 60 critically ill patients, The patients
are from 3 different ICUs: Belgium, Hungary, and New
Zealand (20 patients from each hospital).
Belgian (BE) cohort: This cohort is From the Centre Hos-
pitalier Universitaire of Lige (CHU) ICU, Belgium. The pro-
tocol applied at CHU of Lige targets the 5.6- 8.3 mmol/L
(100-150 mg/dL) band, and is characterized by an insulin
infusion-only approach with a 1- or 4- hour time interval be-
tween BG measurements11.
New Zealand (NZ) cohort: This cohort is from the
Christchurch Hospital ICU, New Zealand, which uses the
stochastic model-based STAR glycemic control protocol.
The STAR protocols adjust both insulin and nutrition lev-
els, measurements taken hourly when outside the 4.4-8.0
mmol/L (80-144 mg/dL) band, and up to 3-hourly within the
band based on nursing choice51213.
Hungarian (HU) cohort: This cohort is from Klmn Pndy
Hospital ICU, Hungary, which also uses their own STAR
version. The insulin delivered as an intravenous infusion
with a higher carbohydrate nutrition formula than the New
Zealand ICU.It has a similar 5 risk of BG<4.4 mmol/L, with
different delivery of insulin and nutrition 14.
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4. Parameter identification (Virtual patient)
In the ICING model in order To generate virtual patients:
clinical data, Real BG measurements and insulin/nutrition
inputs, are used with model Equations (1),(7) to identify
a model-based SI(t) profile for each patient using integral-
based methods in half-hourly bases 14.
SDE can generate unlimited numbers of blood glucose
trajectories for a given SI(t) profile. Thus, it is more diffi-
cult to estimate the model parameters based on experimen-
tal observations which represent only one trajectory of the
stochastic model. For this The Maximum likelihood estima-
tion (MLE) method was used to identify both SI and σ(t)
8.
SI(t) and σ(t) were considered as stepwise functions, that
are constant in each half-hourly intervals. The parameter es-
timation was achieved on the basis of the linear approxima-
tion of the not equidistant blood glucose measurements. The
total treatment time has been divided into half-hourly sec-
tions σ(t) and in every section a new insulin sensitivity value
SI(i) and diffusion term value σ(t) were estimated. The iden-
tification method in details with the equations can be found
in 8.
5. Simulation (Virtual trail )
Also known as in-silico simulation, virtual trails is a stage
where performance is verified before clinical testing .Nu-
merical simulations of the both models with the estimated
parameter profiles and the virtual patient data weer carried
out using ordinary deferential equation solver for ICING and
Runge-Kutta method for SDE with a fix step size of one
minute.
During the simulation in case of SDE the number of
the realizations of the stochastic trajectories varied between
100to500. The analysis considers the mean of the simulated
trajectories.
6. Results
As mentioned in the previous section, SI identification is the
first step in forming the virtual patients. The σ(t) profiles are
also identified for the SDE model. The result of the identi-
fication of a typical patient is shown in Figure 1, Figure 2.
The simulation of the BG values using the two models
solvers for three times 20 patients will result in two BG tra-
jectories for each patients. The two BG trajectories are plot-
ted as a time series function together with the real BG values
extracted from the clinical data in order to visually analyze
and spot the differences and similarities on BG levels. The
plot of one typical patient can be seen in Figure 3.
In order to convert the observational results into a numer-
ical evaluation, the relative and absolute error were calcu-
lated. This numerical evaluation can be used to determine
Figure 1: Stepwise time series function of the identified SI
by ICINC vs. SDE
Figure 2: Stepwise time series function of the identified σ(t)
by SDE
Figure 3: The mean of trajectories of SDE (red) vs. the tra-
jectory of ICING (blue) with the measurements points
Figure 4: The relative error of ICING (blue) vs. SDE (red)
for one typical patient
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the model with lower modelling error and it provides the
possibility for better clinical treatment.
The relative error was used to consider the un-
der/overestimation of the BG levels which can lead to hy-
per/hypoglycemia in the clinical application of the models.
The relative error in each measurement points of one typical
patient can be seen in Figure 4. beginfigure
Both of the models absolute error was compared for all the
three cohorts in every single measurement point (real BG)
, The results of the statistical analysis using Median IQR
for the three cohorts are graphically presented in Figure 5
,Figure 6 ,Figure 7 .
7. Discussion
The stochastic version model allows not only the characteri-
zation of the noise integrated in the stochastic term but also
can show a reduction in the modeling error, and by reduc-
ing the error we may get a presumed improvement under the
STAR protocol using this new stochastic model.
As a first step in this analyses, SI was obtained using the
two models with their different identification methods for
the 3 times 20 patients. This basically leaded to the same
physiological parameter and description of the patient state
with slightly small differences noticed.
Figure 3 shows the time series of the ODE model BG tra-
jectory and the mean of the SDE trajectories together with
the real BG measurements points. It can be seen that the
SDE is more flexible in approaching the real measurement
points in a closer way than the SDE model(smaller error),
also Figure 4 confirms the previous observation, and clearly
shows that the SDE relative error is smaller especially in
cases where the error is big (highly variable patient states).
The Median IQR error statistics results confirms also the
superiority of the SDE model in term of better results with
smaller values (smaller Q1,Q2,Q3 error) in each cohort.
8. Conclusions
The goal of this work was to analyze the potential use of
the stochastic version of the ICING model which is an ex-
tension of the original ordinary differential equation based
ICING model under the STAR protocol using a large clin-
ical data set. The patient records were collected from three
geographically distinct cohorts treated in Belgium, Hungary
and New Zealand. The Method was to analyze the modeling
error that was calculated creating a virtual patients at first
then using in-silico simulation where the blood glucose tra-
jectories were simulated by the two versions of the ICING
model and then compared to the real measurements. The re-
sults show that modeling error of the SDE was smaller com-
pared to the original model in the 3 different cohorts.
Figure 5: The median IQR of SDE(red) vs ICING(blue) of
Hungarian (HU) cohorts
Figure 6: The median IQR of SDE(red) vs ICING(blue) of
New Zealand (NZ) cohorts
Figure 7: The median IQR of SDE(red) vs ICING(blue) of
Belgium (BE) cohorts
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This study provided encouraging results and the question
now: is this reduction in error provided by SDE can lead to
the point where it may be used to improve the prediction
process of the blood glucose level of the ICU patient under
the STAR protocol ? this question can be investigated and
answered in a future work.
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